TITAN PHARMACEUTICALS INC (CIK: 0000910267) EDGAR, Information, Filings... CompaniesBIO.Com

TITAN PHARMACEUTICALS INC

Mailing address
400 OYSTER POINT BLVD, SUITE 505, SAN FRANCISCO, Delaware, 94080
Phone
6502444990
State location
California
State of incorporation
Delaware
Fiscal year end
December 31
SIC
2836 - (CF Office: Office of Life Sciences) BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Filings
N/A

TITAN PHARMACEUTICALS INC (CIK: 0000910267) is an American company incorporated in the state of California. Head office is located at 400 OYSTER POINT BLVD, SUITE 505, SAN FRANCISCO, California, 94080. Work in the industry 2836 - (CF Office: Office of Life Sciences) BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES). TITAN PHARMACEUTICALS INC is a public company and trade via Over-The-Counter (OTC).

Owner	Filings	Transaction Date	Type of Owner
NATAN DAVID	0001253108	Jul-26-2023	director
Beebe Katherine	0001768867	Jul-26-2023	director, officer: President and COO
McMurdo Matthew Charles	0001943108	Jul-26-2023	director
Chasey Peter Louis	0001943351	Jul-26-2023	director
Greenberg Eric Howard	0001943832	Jul-26-2023	director
Ben-Tzvi Avraham	0001944721	Jul-26-2023	director
Choong Choon Hau	0001986021	Jun-23-2023	10 percent owner
Activist Investing LLC	0001817604	Jan-24-2023	other: Member of 10% owner group
Lazar David E.	0001932843	Jan-24-2023	director, 10 percent owner, officer: Chief Executive Officer
MCNAB JAMES R	0001190126	Feb-10-2021	director
Akers Joseph A	0001379888	Feb-10-2021	director
Rubin Marc	0001412377	Feb-10-2021	director, officer: Executive Chairman
Hallberg Dane	0001768844	Feb-19-2019	officer: See Remarks
Recli Federico Seghi	0001739970	May-14-2018	director
Smith Scott Andrew	0001614975	Jan-02-2017	director
Kumar Rajinder	0001693951	Jan-02-2017	director
Harrison Seth Loring	0001404955	Nov-25-2013	10 percent owner
Braeburn Pharmaceuticals BVBA SPRL	0001593438	Nov-25-2013	10 percent owner
Apple Tree Investments S.a.r.l	0001593439	Nov-25-2013	10 percent owner
Apple Tree Partners IV, L.P.	0001593440	Nov-25-2013	10 percent owner
Apple Tree Consolidated BVBA SPRL	0001593452	Nov-25-2013	10 percent owner
ATP III GP, Ltd.	0001593453	Nov-25-2013	10 percent owner
Kapp Joachim Friedrich	0001338543	Aug-31-2005	director
AFTING ERNST GUNTER MD	0001180758	Sep-01-2004	director
MACFARLANE M DAVID	0001182314	Sep-01-2004	director
BAUER VICTOR J PHD	0001180756	Aug-16-2004	director
BHONSLE SUNIL	0001180755	Feb-09-2004	director, officer: Exec. VP & COO
ALLEN RICHARD C	0001180757	Feb-09-2004	officer: Executive Vice President
BUCALO LOUIS R MD	0001180760	Feb-09-2004	director, officer: President and CEO
FARRELL ROBERT EDWARD	0001182315	Feb-09-2004	officer: Exec VP & CFO
WEIS KONRAD M PHD	0001180753	Nov-26-2003	director
HSU MICHAEL	0001180752	Nov-18-2003	director
CAVALLER EURELIO M	0001180754	Oct-31-2003	director
SMITH LEY S	0001180759	Oct-31-2003	director
HUCKEL HUBERT E MD	0001121608	Oct-20-2003	director

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by TITAN PHARMACEUTICALS INC

Filings	Format	Description	Filed/Effective	File/Film Number
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001829126-24-005552 (34 Act) Size: 2547 KB	Aug-15-2024	001-13341 241210846
NT 10-Q	Document	Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB Acc-no: 0001829126-24-005551 (34 Act) Size: 17 KB	Aug-15-2024	001-13341 241210843
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001829126-24-003401 (34 Act) Size: 2467 KB	May-15-2024	001-13341 24950973
RW	Document	Registration Withdrawal Request Acc-no: 0001829126-24-002816 (NE Act) Size: 15 KB	Apr-26-2024	333-272910 24879229
SC 13D/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0001829126-24-002251 (34 Act) Size: 80 KB	Apr-05-2024	005-46083 24826992
3	Document	Initial statement of beneficial ownership of securities Acc-no: 0000921895-24-000809 ( Act) Size: 3 KB	Apr-05-2024
3	Document	Initial statement of beneficial ownership of securities Acc-no: 0000921895-24-000808 ( Act) Size: 3 KB	Apr-05-2024
8-K	Document	Current report filing Acc-no: 0001829126-24-002193 (34 Act) Size: 342 KB	Apr-03-2024	001-13341 24819910
10-K	Document	Annual report pursuant to section 13 and 15(d) Acc-no: 0001829126-24-002110 (34 Act) Size: 6341 KB	Apr-01-2024	001-13341 24810789
8-K	Document	Current report filing Acc-no: 0001829126-24-002106 (34 Act) Size: 199 KB	Apr-01-2024	001-13341 24810681
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001493152-24-011410 ( Act) Size: 7 KB	Mar-27-2024
8-K	Document	Current report filing Acc-no: 0001829126-24-001767 (34 Act) Size: 195 KB	Mar-21-2024	001-13341 24770268
8-K	Document	Current report filing Acc-no: 0001829126-24-000805 (34 Act) Size: 192 KB	Feb-08-2024	001-13341 24606138
8-K	Document	Current report filing Acc-no: 0001829126-24-000395 (34 Act) Size: 201 KB	Jan-25-2024	001-13341 24562664
8-K	Document	Current report filing Acc-no: 0001829126-24-000263 (34 Act) Size: 203 KB	Jan-18-2024	001-13341 24542514
8-K	Document	Current report filing Acc-no: 0001829126-24-000082 (34 Act) Size: 212 KB	Jan-08-2024	001-13341 24521024
8-K	Document	Current report filing Acc-no: 0001829126-23-008273 (34 Act) Size: 236 KB	Dec-28-2023	001-13341 231523021
DEF 14A	Document	Definitive proxy statements Acc-no: 0001829126-23-007698 (34 Act) Size: 134 KB	Nov-28-2023	001-13341 231447197
PRE 14A	Document	Preliminary proxy statement not related to a contested matter or merger/acquisition Acc-no: 0001829126-23-007543 (34 Act) Size: 133 KB	Nov-17-2023	001-13341 231418531
8-K	Document	Current report filing Acc-no: 0001829126-23-007469 (34 Act) Size: 194 KB	Nov-15-2023	001-13341 231410560

Recent 20 filings. View all TITAN PHARMACEUTICALS INC filings

Overall rating 5.0

Aug 22, 2022

Jean Bishop

Very good communication and delivery made within the timeframe I was advised of

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

TITAN PHARMACEUTICALS INC overview
TITAN PHARMACEUTICALS INC job
TITAN PHARMACEUTICALS INC stock
TITAN PHARMACEUTICALS INC ownership
TITAN PHARMACEUTICALS INC CEO
TITAN PHARMACEUTICALS INC documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.